WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 05-Dec-2014 (Data received as of 1-Dec-2014)
Next overall update June 2015
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 912
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 1472

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 10'496  10'195  9'908  9'636  9'381  7'385  6'322  6'090 
Births 461  452  444  436  429  357  302  257 
Surviving infants 424  416  408  400  392  322  263  223 
Pop. less than 5 years 1'957  1'923  1'881  1'826  1'780  1'469  1'181  1'076 
Pop. less than 15 years 4'954  4'838  4'720  4'596  4'486  3'484  2'837  2'662 
Female 15-49 years 2'305  2'226  2'153  2'090  2'028  1'614  1'433  1'399 

Number of reported case

(Click for retrospective incidence data for Somalia)
Diphtheria 65 
Japanese encephalitis
Measles 3'173  9'983  17'298  115  13  3'965 
Mumps
Pertussis 1'001  3'784  3'028  665  823 
Polio* 195  96 
Rubella
Rubella (CRS)
Tetanus (neonatal) 182  224  233  74  53  966 
Tetanus (total) 321  233  74  53 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Somalia)
Vaccine year result method % card seen                                                
BCG          33  37  52  41  29  69 
DTP1          59  76  76  79  79  57 
DTP3          34  61  60  64  51  33 
HepB_BD         
HepB3          34 
Hib3          34 
JapEnc         
MCV          29  49  79  68  65  16 
MCV2         
PCV1         
PCV3         
Pol3          24  47  49  43  37  37 
Rota1         
Rota_last         
Rubella1         
TT2plus 1999  22  MICS     24  52  47  25  43  22 
PAB         
VAD1          14  52  12  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Somalia)
BCG 33  37  39  41  29  69  31 
DTP1 52  52  52  55  52  57  42 
DTP3 42  42  41  45  42  33  19 
HepB3 34 
HepB_BD
Hib3 34 
MCV 46  46  46  46  43  24  30 
MCV2
PAB 64  64  64  64  64  47  49 
PnC3
Pol3 47  47  49  49  41  37  18 
Rota_last
YFV

Number of districts in the country 99  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
85 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes pregnant women and CBAW

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011 -2015  2008 - 2010    NA 
Nº of districts with microplans that include activities to raise immunization coverage number 10  15  89  40 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  Yes  Yes  Yes       

System performance

Total Nº districts in country number 99  20  20  98  113  113  113 
Nº districts with DTP3 coverage >=80% number   20 
% of districts with DTP3 coverage >=80% From 0 to 100%   30  20 
Nº districts with measles (MCV1) coverage >=95% number 16     
% of districts with MCV1 coverage >=95% From 0 to 100% 20  16     

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%      

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.